{"name":"Concordia Laboratories Inc.","slug":"concordia-laboratories-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE1CemxCeXNwRklYMTdGR3BOckZnTENRUHdtQXFRYUVaYkl5alMyb183SFpBZnQzU3hXUUtoM1hIY1d2NGt0dVU4MmgzMjlzUFE?oc=5","date":"2024-10-16","type":"pipeline","source":"cinven.com","summary":"AMCo | Cinven - Focused European Integrated World-class - cinven.com","headline":"AMCo | Cinven - Focused European Integrated World-class","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQbUwwXzRDS09uYnBGazVVaVVDalFNaUFGN3l0Y0FWeUVJWTBDT3RMZmhZSEhWQ1Vlb0VaNVRyZHZiV0lOQUMzdlFSOHNkRHN1emNpdDB0R2k1ZkEwUjh4bmZLLUd5emlQWE9qV01RZ3FhMFVvNTJVMHpoMFVGcVpfcFVSdmJfZw?oc=5","date":"2023-11-30","type":"pipeline","source":"Straits Research","summary":"Polycystic Ovarian Syndrome Treatment Market Size, CAGR of 5.61%, Forecast by 2033 - Straits Research","headline":"Polycystic Ovarian Syndrome Treatment Market Size, CAGR of 5.61%, Forecast by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPVjU0YVZzdnNrZHpLQWFKREhYM0lGYkp1Zk5pUXhyM0xKS1drc09uSk9tc0x1QUJ2LV9oc3BSU0xYWVJ6QktDZHh5NTFadl9yS1VfR3dsWU5OUDlVa3NELUZVQ3JaeUs3VlhSNGJKWmRMSEtrRVlJNURFTm9zbEtkMUxBM1htdHAzeGQ3MDdlemprYU9YRDB1NDJ6bUd1RUhoYXBGZ1hHa1NfQk1lM2M3RFVVaU1CUQ?oc=5","date":"2023-07-14","type":"pipeline","source":"businessinsurance.com","summary":"Pharma entitled to partial reimbursement of defense costs from CNA - businessinsurance.com","headline":"Pharma entitled to partial reimbursement of defense costs from CNA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNU0UwaWhsMzNWclB1NlEzVGtfNTNYYWxVM2pEWEgxX1BPS1Y1LWlMeUZHTW55NmtOZlMxcTBydnNQLWpaWWVnR2dpWk5VdWxQOVBrcVZhMk1DREN5MUhmN1JTYkM0RWxwQWNfMlV6MGNsV0FiT1pPSWotV09zWHpKdk5pUmJZeU1ld2VCdEFlZ2NnSzV3elhjMlZ3?oc=5","date":"2020-04-25","type":"pipeline","source":"openPR.com","summary":"Hydroxychloroquine (Plaquenil) Market to Witness Huge Growth - openPR.com","headline":"Hydroxychloroquine (Plaquenil) Market to Witness Huge Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZ29oaUk0Mm9uYzMyS05YTnFpNGRSZnRINGxyZzNoLXRyR3p1R0txczlUQ2hIMjBvVHJrU3NNWU5lTC1OZlBZX19TZ29FSjd3QjZZTGpOckdnN1JFYXJoeFFqZlRfazNJY2lfanplQ041MG9xd0l2RnNjc0tydXFVMmpRelB1WUpvQncxUXhYeWktUEwybmc?oc=5","date":"2018-11-30","type":"pipeline","source":"Contract Pharma","summary":"Concordia International Becomes ADVANZ PHARMA - Contract Pharma","headline":"Concordia International Becomes ADVANZ PHARMA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZ1BobkN5UWZ0V1NEcUt1TVJCZl9VVU1VNU9xUDhDRjVjSVZGcGNDVXU5NEQ5U3B1NnFyVzBVSXYyR1Y3dTlWRDg3S291Qm9ZNVlCSk5ZRng3SmdxcjNhbVNDZTJJc0hSMTk0OWVTT29JbW9VWURuM0hVQmY4MkY1Vjl2SWZlX2oyS28tSnZ5cU83ZFQ2SHVSTUNnQVhKRk52aDNN?oc=5","date":"2017-11-21","type":"pipeline","source":"GOV.UK","summary":"Drug company accused of abusing its position to overcharge the NHS - GOV.UK","headline":"Drug company accused of abusing its position to overcharge the NHS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOZzhxMXJJWXdacTVtVXdMMkY3N05Na0xHNXgxMmxRWW5kQ0oyTzRmMndIaDRlR3ZIQ0xZb0k2ajlBZlNrZVZ1ZG12UVFBTE1UeFp6T0Y0NHVwTURmd3Y1Vk5QY1ZjeUN5c2JPSTMzbVpqcFJ4M21hZHVRTmR6c0MzdlFQbGs1cHJHY0RUcTV6RjZSVjN0LXpYdG00dWluQ0VHcFd0Ykt0YWdLTEJXZlMtckc5NXp3UEprTlFGeXk0cmpKMDBwWXc?oc=5","date":"2016-01-29","type":"regulatory","source":"The American Bazaar","summary":"Unichem gets USFDA approval to sell tablets for treatment of prostatic hyperplasia - The American Bazaar","headline":"Unichem gets USFDA approval to sell tablets for treatment of prostatic hyperplasia","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}